ArticleClinical and experimental nephrology2019
The urate-lowering efficacy and safety of febuxostat versus allopurinol in Chinese patients with asymptomatic hyperuricemia and with chronic kidney disease stages 3-5.
Xuemei Liu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled ittrialcites it